Inflammation-Induced CNS Glutamate Changes in Depression

Stopped The study was suspended in March 2020 due to the COVID-19 pandemic and ultimately was terminated as it is not safe to test a potent anti-inflammatory drug with ongoing surges of COVID-19.

Conditions

• Depression

Interventions

• DRUG: Infliximab
• DRUG: Placebo

Sponsor

Emory University

Collaborators

• [object Object]